Lucian Iancovici
Director/Board Member bij RALLYBIO CORPORATION
Profiel
Lucian Iancovici is currently a Director at ViaCyte, Inc., a Director at Sionna Therapeutics, Inc., an Independent Director at Rallybio Corp., a Director at Sling Therapeutics, Inc., a Partner at TPG Growth LLC, and a Partner at FS Investors.
He previously worked as a Director at Welltok, Inc., a Principal at TPG Capital LLC, an Associate at McKinsey & Co., Inc., the Head of Qualcomm Life Fund at QUALCOMM Ventures, and a General Partner at dRx Capital AG.
Dr. Iancovici obtained his undergraduate degree from Tufts University and his doctorate from Tufts University School of Medicine.
Actieve functies van Lucian Iancovici
Bedrijven | Functie | Begin |
---|---|---|
RALLYBIO CORPORATION | Director/Board Member | 01-05-2020 |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Director/Board Member | - |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Private Equity Investor | 01-01-2018 |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Director/Board Member | - |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Director/Board Member | - |
FS Investors
FS Investors Investment ManagersFinance FS Investors (FS I) is a private equity/venture capital firm founded in 2011 by Mike Stone. The firm is headquartered in La Jolla, California. | Private Equity Investor | 01-10-2017 |
Eerdere bekende functies van Lucian Iancovici
Bedrijven | Functie | Einde |
---|---|---|
QUALCOMM Ventures
QUALCOMM Ventures Investment ManagersFinance QUALCOMM Ventures (QUALCOMM Ventures) is a venture capital subsidiary of QUALCOMM, Inc. The firm is headquartered in San Diego, California. | Corporate Officer/Principal | 01-10-2017 |
dRx Capital AG
dRx Capital AG Investment ManagersFinance dRx Capital AG (dRx Capital) is a investment arm of Novartis AG founded in 2015 by Valencia Rick. The firm is headquartered in Cambridge, Massachusetts. | Private Equity Investor | 01-10-2017 |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Private Equity Analyst | 01-09-2012 |
░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Lucian Iancovici
Tufts University | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RALLYBIO CORPORATION | Health Technology |
Bedrijven in privébezit | 10 |
---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Welltok, Inc.
Welltok, Inc. Packaged SoftwareTechnology Services Welltok, Inc. is a consumer activation solutions company that improves people's total wellbeing. It offers proprietary data, advanced analytics, software-as-a-service software, and professional services to engage consumers in personalized and rewarding ways to drive action. The company was founded Jeff Cohen, Carlos C. Cardona, Scott Rotermund, Chris Rotermund, Christopher Coloian, Stanley J. Nowak III, Paulo Matos, Patrick D. Mize, and John DiBiasi in 2009 and is headquartered in Denver, CO. | Technology Services |
TPG Capital LLC
TPG Capital LLC Investment ManagersFinance TPG Capital LLC is a Private Equity firm, a subsidiary of TPG Capital Advisors LLC founded in 1992 by William S. Price and James George Coulter. The firm is headquartered in Fort Worth with additional offices in London and São Paulo. | Finance |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
TPG Growth LLC
TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
QUALCOMM Ventures
QUALCOMM Ventures Investment ManagersFinance QUALCOMM Ventures (QUALCOMM Ventures) is a venture capital subsidiary of QUALCOMM, Inc. The firm is headquartered in San Diego, California. | Finance |
dRx Capital AG
dRx Capital AG Investment ManagersFinance dRx Capital AG (dRx Capital) is a investment arm of Novartis AG founded in 2015 by Valencia Rick. The firm is headquartered in Cambridge, Massachusetts. | Finance |
FS Investors
FS Investors Investment ManagersFinance FS Investors (FS I) is a private equity/venture capital firm founded in 2011 by Mike Stone. The firm is headquartered in La Jolla, California. | Finance |
Sionna Therapeutics, Inc.
Sionna Therapeutics, Inc. Medical/Nursing ServicesHealth Services Sionna Therapeutics, Inc. is a clinical-stage life sciences company located in Natick, MA. The company is dedicated to developing highly effective and differentiated treatments for cystic fibrosis (CF) by normalizing the function of CFTR, the key protein associated with disease progression in CF. Sionna is advancing a pipeline of small molecules engineered to correct the protein defects caused by ?F508, the most common mutation that affects the CFTR protein. The company has a first-in-class portfolio of programs directly targeting correction of ?F508-CFTR, the key and unique mechanism to enable full restoration of ?F508-CFTR function, and complementary programs targeting ICL4 and more. The CEO of the company is Michael Cloonan. | Health Services |
Sling Therapeutics, Inc.
Sling Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sling Therapeutics, Inc. is a company dedicated to developing impactful and high-quality clinical therapies for patients. Sling Therapeutics is located in Ann Arbor, MI and was founded by Gary D. Hammer. The company's pipeline includes linsitinib, an oral therapy being developed for thyroid eye disease (TED) that has established a safety profile through treatment of over 800 patients. The company is focused on bringing additional treatment options to patients, as well as the ophthalmology, endocrinology, and rare disease communities. Sling Therapeutics welcomes collaboration in this mission. The CEO is Ryan Zeidan. | Commercial Services |